Actavis Plc is in advanced talks to acquire rival drug maker Forest Laboratories Inc in a deal that could value Forest at up to $25 billion, the Wall Street Journal reported citing people familiar with the matter. The deal is expected to be announced as early as Tuesday, but it is possible that the talks could still fall apart, the Journal said. ()
Shares of ACT traded higher by 0.13% or $0.25/share to $191.88. In the past year, the shares have traded as low as $82.02 and as high as $193.21. On average, 1360750 shares of ACT exchange hands on a given day and today's volume is recorded at 763671.
Forest Laboratories, Inc. (Forest) develops, manufactures and sells branded forms of ethical drug products, which requires a physician's prescription. Shares of FRX traded higher by 1.49% or $1.05/share to $71.39. In the past year, the shares have traded as low as $35.22 and as high as $72.40. On average, 2216920 shares of FRX exchange hands on a given day and today's volume is recorded at 2690634.
Source
